Header Logo

Michael S Cookson

TitleProf & Chair
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDept of Urology
AddressWP 2140
920 Stanton L Young Blvd
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86. PMID: 38704840.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    2. Shore ND, Antonarakis ES, Ross AE, Marshall CH, Stratton KL, Ayanambakkam A, Cookson MS, McKay RR, Bryce AH, Kaymakcalan MD. Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Apr 20. PMID: 38643308.
      Citations:    Fields:    
    3. Bryce AH, Crawford ED, Agarwal N, Hussain MH, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU Open Plus. 2024 Apr; 2(4). PMID: 38774467; PMCID: PMC11107999.
      Citations:    
    4. Crawford ED, Bryce AH, Hussain MH, Agarwal N, Beltran H, Cooperberg MR, Petrylak DP, Shore N, Spratt DE, Tagawa ST, Antonarakis ES, Aparicio AM, Armstrong AJ, Boike TP, Calais J, Carducci MA, Chapin BF, Cookson MS, Davis JW, Dorff T, Eggener SE, Feng FY, Gleave M, Higano C, Iagaru A, Morgans AK, Morris M, Murray KS, Poage W, Rettig MB, Sartor O, Scher HI, Sieber P, Small E, Srinivas S, Yu EY, Zhang T, Koo PJ. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU Open Plus. 2024 Apr; 2(4). PMID: 38774466; PMCID: PMC11108024.
      Citations: 1     
    5. Spratt DE, George DJ, Shore ND, Cookson MS, Saltzstein DR, Tutrone R, Bossi A, Brown BA, Lu S, Fallick M, Hanson S, Tombal BF. Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. JAMA Oncol. 2024 Mar 07. PMID: 38451492; PMCID: PMC10921349.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    6. Shore N, Antonarakis E, Ross A, Marshall C, Stratton K, Ayanambakkam A, Cookson M, McKay R, Bryce A, Kaymakcalan M. A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Mar 02. PMID: 38431761.
      Citations:    Fields:    
    7. Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024 02 12; 384:e076743. PMID: 38346808.
      Citations: 21     Fields:    Translation:Humans
    8. Tutrone R, Saad F, George DJ, Tombal B, Bailen JL, Cookson MS, Saltzstein DR, Hanson S, Brown B, Lu S, Fallick M, Shore ND. Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. Eur Urol Oncol. 2023 Dec 23. PMID: 38143206.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    9. Shore ND, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford D, Tombal B, Nordquist L, Cookson M, Verholen F, Jhaveri J, Srinivasan S, Smith MR. Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial. Oncologist. 2023 Oct 09. PMID: 37812679.
      Citations:    Fields:    Translation:Humans
    10. Saad F, George DJ, Cookson MS, Saltzstein DR, Tutrone R, Bossi A, Brown B, Selby B, Lu S, Tombal B, Shore ND. Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer. Cancers (Basel). 2023 Oct 05; 15(19). PMID: 37835548; PMCID: PMC10571668.
      Citations: 1     
    11. Ho MD, Black AJ, Zargar H, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Vasdev N, Sridhar SS, McGrath JS, Aning J, Holzbeierlein JM, Thorpe AC, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy. Can Urol Assoc J. 2023 Oct; 17(10):301-309. PMID: 37851909; PMCID: PMC10581722.
      Citations: 2     
    12. Shore ND, Mehlhaff BA, Cookson MS, Saltzstein DR, Tutrone R, Brown B, Lu S, Fallick M, Hanson S, Saad F. Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer. Adv Ther. 2023 Sep 15. PMID: 37713020.
      Citations:    Fields:    Translation:Humans
    13. Lowrance W, Dreicer R, Jarrard DF, Scarpato KR, Kim SK, Kirkby E, Buckley DI, Griffin JC, Cookson MS. Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023). J Urol. 2023 Apr 25; 101097JU0000000000003452. PMID: 37096583.
      Citations: 26     Fields:    Translation:Humans
    14. George DJ, Saad F, Cookson MS, Saltzstein DR, Tutrone R, Bossi A, Brown B, Selby B, Lu S, Buckley D, Tombal B, Shore ND. Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer. Clin Genitourin Cancer. 2023 Mar 24. PMID: 37062659.
      Citations: 3     Fields:    Translation:Humans
    15. Kirk PS, Lotan Y, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Spiess PE, van Rhijn BWG, Mertens L, Black P, Wright JL. Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort. J Urol. 2023 05; 209(5):882-889. PMID: 36795962.
      Citations: 4     Fields:    Translation:Humans
    16. Einerhand SMH, Black AJ, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, van Rhijn BWG, Black PC, Mertens LS. Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer. World J Urol. 2022 Nov; 40(11):2707-2715. PMID: 36169695.
      Citations:    Fields:    Translation:Humans
    17. Gonzalez V, Suflita M, Janitz A, Campbell J, McIntosh AG, Stratton K, Cookson MS, Parker DC. Kidney Cancer Incidence and Mortality Disparities Involving American Indians/Alaska Natives: An Analysis of the Oklahoma Central Cancer Registry (OCCR). J Cancer Epidemiol. 2022; 2022:2689386. PMID: 35769890.
      Citations: 1     
    18. Tan WS, Steinberg G, Witjes JA, Li R, Shariat SF, Roupret M, Babjuk M, Bivalacqua TJ, Psutka SP, Williams SB, Cookson MS, Palou J, Kamat AM. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol. 2022 Oct; 5(5):505-516. PMID: 35718695.
      Citations: 6     Fields:    Translation:Humans
    19. Mir MC, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, McGrath JS, Kassouf W, Dall'Era MA, Sridhar SS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Black PC. Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]. Eur Urol Focus. 2022 Feb 15. PMID: 35181282.
      Citations:    Fields:    
    20. Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 03; 81(3):223-228. PMID: 34933753.
      Citations: 3     Fields:    Translation:Humans
    21. Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz LH, Loblaw A, Mamedov A, Goldenberg SL, Higano CS, Spillane M, Wu E, Carter HB, Pavlovich CP, Mamawala M, Landis T, Carroll PR, Chan JM, Cooperberg MR, Cowan JE, Morgan TM, Siddiqui J, Martin R, Klein EA, Brittain K, Gotwald P, Barocas DA, Dallmer JR, Gordetsky JB, Steele P, Kundu SD, Stockdale J, Roobol MJ, Venderbos LDF, Sanda MG, Arnold R, Patil D, Evans CP, Dall'Era MA, Vij A, Costello AJ, Chow K, Corcoran NM, Rais-Bahrami S, Phares C, Scherr DS, Flynn T, Karnes RJ, Koch M, Dhondt CR, Nelson JB, McBride D, Cookson MS, Stratton KL, Farriester S, Hemken E, Stadler WM, Pera T, Banionyte D, Bianco FJ, Lopez IH, Loeb S, Taneja SS, Byrne N, Amling CL, Martinez A, Boileau L, Gaylis FD, Petkewicz J, Kirwen N, Helfand BT, Xu J, Scholtens DM, Catalona WJ, Witte JS. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. HGG Adv. 2022 Jan 13; 3(1). PMID: 34993496.
      Citations: 12     Fields:    
    22. D'Andrea D, Black PC, Zargar H, Dinney CP, Soria F, Cookson MS, Montgomery JS, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Wright JL, Thorpe AC, Holzbeierlein JM, Carrión DM, Di Trapani E, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer. J Urol. 2022 01; 207(1):70-76. PMID: 34445891.
      Citations: 5     Fields:    Translation:Humans
    23. D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Soria F, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2021 Dec; 39(12):4345-4354. PMID: 34370078.
      Citations: 1     Fields:    Translation:Humans
    24. Bandres-Ciga S, Saez-Atienzar S, Kim JJ, Makarious MB, Faghri F, Diez-Fairen M, Iwaki H, Leonard H, Botia J, Ryten M, Hernandez D, Gibbs JR, Ding J, Gan-Or Z, Noyce A, Pihlstrom L, Torkamani A, Soltis AR, Dalgard CL, Scholz SW, Traynor BJ, Ehrlich D, Scherzer CR, Bookman M, Cookson M, Blauwendraat C, Nalls MA, Singleton AB. Correction to: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 2021 Jul; 142(1):223-224. PMID: 33944973.
      Citations:    Fields:    
    25. Shepherd C, Cookson M, Shore N. The Growth of Integrated Care Models in Urology. Urol Clin North Am. 2021 May; 48(2):223-232. PMID: 33795056.
      Citations:    Fields:    Translation:Humans
    26. Lange PH, Cookson MS, Schellhammer PF, Droller MJ. A history of the Society of Urologic Oncology. Urol Oncol. 2021 09; 39(9):514-520. PMID: 33454198.
      Citations:    Fields:    
    27. Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117. PMID: 33253641.
      Citations: 105     Fields:    Translation:HumansCellsCTClinical Trials
    28. Soria F, Black PC, Fairey AS, Cookson MS, Yu EY, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Daneshmand S, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Shariat SF, Gontero P. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis. BJU Int. 2021 07; 128(1):79-87. PMID: 33152179.
      Citations: 10     Fields:    Translation:Humans
    29. D'Andrea D, Matin S, Black PC, Petros FG, Zargar H, Dinney CP, Cookson MS, Kassouf W, Dall'Era MA, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, Sridhar SS, North S, Barocas DA, Lotan Y, Stephenson AJ, van Rhijn BW, Spiess PE, Daneshmand S, Shariat SF. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU Int. 2021 05; 127(5):528-537. PMID: 32981193.
      Citations: 5     Fields:    Translation:Humans
    30. Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, Jarrard DF, Kibel AS, Morgan TM, Morgans AK, Oh WK, Resnick MJ, Zietman AL, Cookson MS. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021 Jan; 205(1):22-29. PMID: 32960678.
      Citations: 54     Fields:    Translation:Humans
    31. Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, Jarrard DF, Kibel AS, Morgan TM, Morgans AK, Oh WK, Resnick MJ, Zietman AL, Cookson MS. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21. PMID: 32960679.
      Citations: 84     Fields:    Translation:Humans
    32. Mir MC, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, McGrath JS, Kassouf W, Dall'Era MA, Sridhar SS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand D, Black PC. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. Eur Urol Focus. 2021 Nov; 7(6):1347-1354. PMID: 32771446.
      Citations: 15     Fields:    Translation:Humans
    33. Bandres-Ciga S, Saez-Atienzar S, Kim JJ, Makarious MB, Faghri F, Diez-Fairen M, Iwaki H, Leonard H, Botia J, Ryten M, Hernandez D, Gibbs JR, Ding J, Gan-Or Z, Noyce A, Pihlstrom L, Torkamani A, Soltis AR, Dalgard CL, Scholz SW, Traynor BJ, Ehrlich D, Scherzer CR, Bookman M, Cookson M, Blauwendraat C, Nalls MA, Singleton AB. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 2020 09; 140(3):341-358. PMID: 32601912.
      Citations: 44     Fields:    Translation:HumansCells
    34. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811. PMID: 32516092.
      Citations: 100     Fields:    Translation:Humans
    35. Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 06 04; 382(23):2187-2196. PMID: 32469183.
      Citations: 135     Fields:    Translation:HumansCTClinical Trials
    36. Dupont WD, Breyer JP, Plummer WD, Chang SS, Cookson MS, Smith JA, Blue EE, Bamshad MJ, Smith JR. 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer. Nat Commun. 2020 03 23; 11(1):1523. PMID: 32251286.
      Citations: 10     Fields:    Translation:HumansCells
    37. Shore ND, Antonarakis ES, Cookson MS, Crawford ED, Morgans AK, Albala DM, Hafron J, Harris RG, Saltzstein D, Brown GA, Henderson J, Lowentritt B, Spier JM, Concepcion R. Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines. Prostate. 2020 05; 80(6):527-544. PMID: 32130741.
      Citations: 28     Fields:    Translation:Humans
    38. D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Zehetmayer S, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Shariat SF. Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. Urol Oncol. 2020 07; 38(7):639.e1-639.e9. PMID: 32057595.
      Citations: 5     Fields:    Translation:Humans
    39. Patel S, Cookson M. Editorial Comment. J Urol. 2020 05; 203(5):931-932. PMID: 32011201.
      Citations:    Fields:    Translation:Humans
    40. Parker DC, Cookson MS. The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer. Investig Clin Urol. 2020 02; 61(Suppl 1):S3-S7. PMID: 32055749.
      Citations: 3     Fields:    Translation:Humans
    41. Black AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Sridhar SS, Black PC. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Urol Oncol. 2020 01; 38(1):3.e17-3.e27. PMID: 31676278.
      Citations: 26     Fields:    Translation:HumansCells
    42. Cookson MS. Urology perspective on the expanding world of germline testing for prostate cancer. Can J Urol. 2019 10; 26(5 Suppl 2):5-6. PMID: 31629413.
      Citations:    Fields:    Translation:Humans
    43. Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Soodana-Prakash N, Becerra MF, Swain S, Kendrick K, Smith JA, Thompson IM, Parekh DJ. Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup. J Urol. 2020 03; 203(3):522-529. PMID: 31549935.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    44. Ritch CR, Cookson MS, Clark PE, Chang SS, Fakhoury K, Ralls V, Thu MH, Penson DF, Smith JA, Silver HJ. Reply by Authors. J Urol. 2019 10; 202(4):820. PMID: 31166841.
      Citations:    Fields:    Translation:Humans
    45. Ritch CR, Cookson MS, Clark PE, Chang SS, Fakhoury K, Ralls V, Thu MH, Penson DF, Smith JA, Silver HJ. Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial. J Urol. 2019 03; 201(3):470-477. PMID: 30359680.
      Citations: 28     Fields:    Translation:Humans
    46. Abboud MA, Topham AK, Parker DC, Burks HR, Cookson MS, Patel SG. Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer. Urology. 2019 Jan; 123:181-185. PMID: 30359713.
      Citations:    Fields:    Translation:Humans
    47. Ritch C, Cookson M. Recent trends in the management of advanced prostate cancer. F1000Res. 2018; 7. PMID: 30345007.
      Citations: 37     Fields:    Translation:Humans
    48. Fernández MI, Brausi M, Clark PE, Cookson MS, Grossman HB, Khochikar M, Kiemeney LA, Malavaud B, Sanchez-Salas R, Soloway MS, Svatek RS, Vikram R, Vrieling A, Kamat AM. Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer. World J Urol. 2019 Jan; 37(1):3-13. PMID: 30105454.
      Citations: 28     Fields:    Translation:Humans
    49. Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018. J Urol. 2018 12; 200(6):1264-1272. PMID: 30086276.
      Citations: 53     Fields:    Translation:Humans
    50. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA, Thompson IM. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 06 23; 391(10139):2525-2536. PMID: 29976469.
      Citations: 202     Fields:    Translation:HumansCTClinical Trials
    51. Patel S, Cookson MS. Editorial Comment. J Urol. 2018 08; 200(2):290-291. PMID: 29777651.
      Citations:    Fields:    Translation:Humans
    52. Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Holzbeierlein JM, Thorpe A, Black PC. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy. World J Urol. 2019 Jan; 37(1):165-172. PMID: 29882105.
      Citations: 1     Fields:    Translation:Humans
    53. Parker DC, Cookson MS. Editorial Commentary. Urol Pract. 2018 Sep; 5(5):389. PMID: 37312335.
      Citations:    Fields:    
    54. Lotan Y, Black PC, Caba L, Chang SS, Cookson MS, Daneshmand S, Kamat AM, McKiernan JM, Pruthi RS, Ritch CR, Steinberg GD, Svatek RS, Zwarthoff EC. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. Eur Urol Oncol. 2018 08; 1(3):223-230. PMID: 31102625.
      Citations: 13     Fields:    Translation:Humans
    55. Thress TM, Cookson MS, Patel S. Robotic Cystectomy with Intracorporeal Urinary Diversion: Review of Current Techniques and Outcomes. Urol Clin North Am. 2018 Feb; 45(1):67-77. PMID: 29169452.
      Citations: 6     Fields:    Translation:Humans
    56. Cookson MS. Urinary Diversion: Nutritional Evolution and Surgical Revolution. Urol Clin North Am. 2018 02; 45(1):xvii. PMID: 29169456.
      Citations:    Fields:    Translation:Humans
    57. Cookson MS. Editorial Commentary. Urol Pract. 2018 Mar; 5(2):160. PMID: 37300210.
      Citations:    Fields:    
    58. Xia D, Lai DV, Wu W, Webb ZD, Yang Q, Zhao L, Yu Z, Thorpe JE, Disch BC, Ihnat MA, Jayaraman M, Dhanasekaran DN, Stratton KL, Cookson MS, Fung KM, Lin HK. Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98. PMID: 29155210.
      Citations: 7     Fields:    Translation:HumansCells
    59. Nguyen KD, Hyder ZZ, Shaw MD, Maness SB, Cookson MS, Patel SG, Stratton KL. Effects of primary care physician density, urologist presence, and insurance status on stage of diagnosis for urologic malignancies. Cancer Epidemiol. 2018 02; 52:10-14. PMID: 29145004.
      Citations: 6     Fields:    Translation:Humans
    60. Stratton K, Cookson M. Castration-Resistant Prostate Cancer: An Algorithmic Approach. Urol Clin North Am. 2017 Nov; 44(4):647-655. PMID: 29107280.
      Citations: 1     Fields:    Translation:Humans
    61. Maloney I, Parker DC, Cookson MS, Patel S. Bladder Cancer Recovery Pathways: A Systematic Review. Bladder Cancer. 2017 Oct 27; 3(4):269-281. PMID: 29152551.
      Citations: 5     
    62. Haddad J, Anderson C, Heinlen J, Stratton K, Mellis A, Herr H, Cookson M, Patel S. Improving the quality of operative reports for transurethral resection of bladder tumor surgery in resident education. Can J Urol. 2017 Oct; 24(5):8976-8981. PMID: 28971783.
      Citations: 4     Fields:    Translation:Humans
    63. Cookson MS. Editorial Commentary. Urol Pract. 2017 Nov; 4(6):466-467. PMID: 37300150.
      Citations:    Fields:    
    64. Heinlen JE, Salinas L, Cookson MS. Clostridium difficile Infection in Contemporary Urologic Practice. Urology. 2018 Jan; 111:23-27. PMID: 28688849.
      Citations: 1     Fields:    Translation:Humans
    65. Cross BW, Parker DC, Cookson MS. Salvage Surgery After Renal Mass Ablation. Urol Clin North Am. 2017 May; 44(2):305-312. PMID: 28411921.
      Citations: 1     Fields:    Translation:Humans
    66. Cookson MS. Editorial Commentary. Urol Pract. 2017 May; 4(3):238. PMID: 37592657.
      Citations:    Fields:    
    67. Bachman AG, Parker AA, Shaw MD, Cross BW, Stratton KL, Cookson MS, Patel SG. Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database. Urology. 2017 May; 103:99-105. PMID: 28214574.
      Citations: 13     Fields:    Translation:Humans
    68. Glaser ZA, Love HD, Guo S, Gellert L, Chang SS, Herrell SD, Barocas DA, Penson DF, Cookson MS, Clark PE. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Urol Oncol. 2017 05; 35(5):286-293. PMID: 28108243.
      Citations: 13     Fields:    Translation:HumansCells
    69. Ritch CR, Cookson MS. Advances in the management of castration resistant prostate cancer. BMJ. 2016 Oct 17; 355:i4405. PMID: 27754846.
      Citations: 47     Fields:    Translation:Humans
    70. Gregg JR, Emeruwa C, Wong J, Barocas DA, Chang SS, Clark PE, Cookson MS, Penson DF, Resnick MJ, Scarpato KR, Smith JA, Moses KA. Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women. J Urol. 2016 Oct; 196(4):1030-5. PMID: 27164514.
      Citations: 10     Fields:    Translation:Humans
    71. Kamat AM, Cookson M, Witjes JA, Stenzl A, Grossman HB. The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis. Bladder Cancer. 2016 Apr 27; 2(2):273-278. PMID: 27376146.
      Citations: 20     
    72. Anderson C, Weber R, Patel D, Lowrance W, Mellis A, Cookson M, Lang M, Barocas D, Chang S, Newberger E, Montgomery JS, Weizer AZ, Lee CT, Kava BR, Jackson M, Meraney A, Sjoberg D, Bochner B, Dalbagni G, Donat M, Herr H. A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor. J Urol. 2016 Oct; 196(4):1014-20. PMID: 27044571.
      Citations: 19     Fields:    Translation:Humans
    73. Gregg JR, McCormick B, Wang L, Cohen P, Sun D, Penson DF, Smith JA, Clark PE, Cookson MS, Barocas DA, Resnick MJ, Moses KA, Chang SS. Short term complications from transurethral resection of bladder tumor. Can J Urol. 2016 Apr; 23(2):8198-203. PMID: 27085823.
      Citations: 23     Fields:    Translation:Humans
    74. Stratton KL, Moeller AM, Cookson MS. Implementation of the AUA Castration Resistant Prostate Cancer Guidelines into Practice: Establishing a Multidisciplinary Clinic. Urol Pract. 2016 May; 3(3):203-209. PMID: 37592460.
      Citations:    Fields:    
    75. Geethakumari PR, Cookson MS, Kelly WK. The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3. Oncology (Williston Park). 2016 Feb; 30(2):187-95, 199. PMID: 26888794.
      Citations: 5     Fields:    Translation:HumansCells
    76. Patel S, Cookson MS. Radical Cystectomy-The Waiting is the Hardest Part…or is it? J Urol. 2016 04; 195(4 Pt 1):821-2. PMID: 26804430.
      Citations:    Fields:    Translation:Humans
    77. Lowrance WT, Roth BJ, Kirkby E, Murad MH, Cookson MS. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015. J Urol. 2016 May; 195(5):1444-1452. PMID: 26498056.
      Citations: 27     Fields:    Translation:Humans
    78. Cookson M, Stratton K. Editorial Comment for Bolton et al. J Endourol. 2015 Jul; 29(7):850. PMID: 25936402.
      Citations:    Fields:    Translation:Humans
    79. Reddy OL, Cates JM, Gellert LL, Crist HS, Yang Z, Yamashita H, Taylor JA, Smith JA, Chang SS, Cookson MS, You C, Barocas DA, Grabowska MM, Ye F, Wu XR, Yi Y, Matusik RJ, Kaestner KH, Clark PE, DeGraff DJ. Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer. Am J Pathol. 2015 May; 185(5):1385-95. PMID: 25907831.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    80. Kim M, Lee HE, Kim SH, Cho SY, Jeong SJ, Oh SJ, Cookson MS, Ku JH. Korean version of the functional assessment of cancer therapy (FACT)-vanderbilt cystectomy index (VCI): translation and linguistic. Urol J. 2014 Nov 30; 11(6):1961-7. PMID: 25433475.
      Citations: 5     Fields:    Translation:Humans
    81. Casey RG, Catto JW, Cheng L, Cookson MS, Herr H, Shariat S, Witjes JA, Black PC. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015 May; 67(5):876-88. PMID: 25466937.
      Citations: 23     Fields:    Translation:Humans
    82. Cookson MS, Lowrance WT, Murad MH, Kibel AS. Castration-resistant prostate cancer: AUA guideline amendment. J Urol. 2015 Feb; 193(2):491-9. PMID: 25444753.
      Citations: 35     Fields:    Translation:Humans
    83. Kaffenberger SD, Lin-Tsai O, Stratton KL, Morgan TM, Barocas DA, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma. Urol Oncol. 2015 Jan; 33(1):21.e11-21.e17. PMID: 25456998.
      Citations: 13     Fields:    Translation:Humans
    84. Cookson MS, Chang SS, Lihou C, Li T, Harper SQ, Lang Z, Tutrone RF. Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder. Ther Adv Urol. 2014 Oct; 6(5):181-91. PMID: 25276228.
      Citations: 11     
    85. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. PMID: 25245244.
      Citations: 25     Fields:    Translation:Humans
    86. Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Garcia JA, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Black PC. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2015 Feb; 67(2):241-9. PMID: 25257030.
      Citations: 116     Fields:    Translation:Humans
    87. Eifler JB, Cookson MS. Best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy. Urol Clin North Am. 2014 Nov; 41(4):493-502. PMID: 25306161.
      Citations: 3     Fields:    Translation:Humans
    88. Stimson CJ, Resnick MJ, Patel SG, Zaid HB, Cookson MS, Penson DF, Smith JA, Chang SS, Barocas DA. The Influence of Access Related Factors on Adherence to Clinical Practice Guidelines for Muscle Invasive Bladder Cancer. Urol Pract. 2014 Sep; 1(3):127-133. PMID: 37537826.
      Citations:    Fields:    
    89. Ritch CR, Cookson MS, Chang SS, Clark PE, Resnick MJ, Penson DF, Smith JA, May AT, Anderson CB, You C, Lee H, Barocas DA. Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy. J Urol. 2014 Nov; 192(5):1360-4. PMID: 24928268.
      Citations: 14     Fields:    Translation:Humans
    90. Ritch CR, You C, May AT, Herrell SD, Clark PE, Penson DF, Chang SS, Cookson MS, Smith JA, Barocas DA. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer. Urology. 2014 Jun; 83(6):1309-15. PMID: 24746665.
      Citations: 14     Fields:    Translation:Humans
    91. Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, Cookson MS, Penson DF, Davis R, Clark PE, Smith JA, Chang SS. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int. 2014 Jun; 113(6):894-9. PMID: 24053444.
      Citations: 33     Fields:    Translation:Humans
    92. Shore ND, Cookson MS. Proper Sequencing of Treatment for Castrate Resistant Prostate Cancer. Urol Pract. 2014 May; 1(1):2-6. PMID: 37533220.
      Citations:    Fields:    
    93. Breyer JP, Dorset DC, Clark TA, Bradley KM, Wahlfors TA, McReynolds KM, Maynard WH, Chang SS, Cookson MS, Smith JA, Schleutker J, Dupont WD, Smith JR. An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility. Am J Hum Genet. 2014 Mar 06; 94(3):395-404. PMID: 24581739.
      Citations: 19     Fields:    Translation:HumansCells
    94. Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. 2015 Jan; 67(1):165-170. PMID: 24472710.
      Citations: 89     Fields:    Translation:Humans
    95. Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA, Penson DF. Racial variation in the quality of surgical care for bladder cancer. Cancer. 2014 Apr 01; 120(7):1018-25. PMID: 24339051.
      Citations: 21     Fields:    Translation:Humans
    96. Eifler JB, Cookson MS. Prostate cancer: Could sensitive PSA assays expedite salvage radiotherapy? Nat Rev Urol. 2014 Jan; 11(1):14-5. PMID: 24296701.
      Citations:    Fields:    Translation:Humans
    97. Zaid HB, Patel SG, Stimson CJ, Resnick MJ, Cookson MS, Barocas DA, Chang SS. Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database. Urology. 2014 Jan; 83(1):75-80. PMID: 24231210.
      Citations: 63     Fields:    Translation:Humans
    98. Thompson IM, Kappa SF, Morgan TM, Barocas DA, Bischoff CJ, Keegan KA, Stratton KL, Clark PE, Resnick MJ, Smith JA, Cookson MS, Chang SS. Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device. Urol Oncol. 2014 Jan; 32(1):45.e11-5. PMID: 24054870.
      Citations: 6     Fields:    Translation:Humans
    99. Patel SG, Stimson CJ, Zaid HB, Resnick MJ, Cookson MS, Barocas DA, Chang SS. Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns. J Urol. 2014 Feb; 191(2):329-34. PMID: 24036236.
      Citations: 19     Fields:    Translation:Humans
    100. Ferguson RW, Shields W, Cookson M, Gielen AC. Utilizing E-coded data for nonfatal injury surveillance in the pediatric emergency department setting: a literature review and recommendations. Pediatr Emerg Care. 2013 Jul; 29(7):801-5. PMID: 23823257.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    101. Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS. Castration-resistant prostate cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):429-38. PMID: 23665272.
      Citations: 107     Fields:    Translation:Humans
    102. Resnick MJ, Cookson MS. Positive surgical margins at radical prostatectomy: much ado about nothing? Urol Oncol. 2013 Apr; 31(3):285-7. PMID: 23627001.
      Citations: 1     Fields:    Translation:Humans
    103. Hansel DE, Miller JS, Cookson MS, Chang SS. Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist. Urology. 2013 Jun; 81(6):1123-30. PMID: 23522296.
      Citations: 7     Fields:    Translation:Humans
    104. Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol. 2013 Jun; 189(6):2039-46. PMID: 23485507.
      Citations: 80     Fields:    Translation:Humans
    105. Moore DC, Keegan KA, Resnick MJ, Eisenberg R, Holt GE, Cookson MS. A 57-year-old man with a history of prostatectomy and pelvic irradiation presents with recurrent urinary tract infections, hematuria, and pelvic pain. Urology. 2013 Feb; 81(2):221-5. PMID: 23374762.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    106. Larré S, Catto JW, Cookson MS, Messing EM, Shariat SF, Soloway MS, Svatek RS, Lotan Y, Zlotta AR, Grossman HB. Screening for bladder cancer: rationale, limitations, whom to target, and perspectives. Eur Urol. 2013 Jun; 63(6):1049-58. PMID: 23313034.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    107. Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R, Penson DF, Barocas DA, Smith JA, Cookson MS, Chang SS. Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol. 2013 Feb; 189(2):541-7. PMID: 23260561.
      Citations: 39     Fields:    Translation:Humans
    108. Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF. Volume outcomes of cystectomy--is it the surgeon or the setting? J Urol. 2012 Dec; 188(6):2139-44. PMID: 23083864.
      Citations: 15     Fields:    Translation:Humans
    109. Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, Penson DF, Davis R, Clark PE, Chang SS, Cookson MS, Herrell SD, Smith JA. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol. 2013 Feb; 189(2):507-13. PMID: 23000849.
      Citations: 24     Fields:    Translation:Humans
    110. Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int. 2012 Dec; 110(11 Pt B):E641-6. PMID: 22958439.
      Citations: 30     Fields:    Translation:Humans
    111. Barocas DA, Gray DT, Fowke JH, Mercaldo ND, Blume JD, Chang SS, Cookson MS, Smith JA, Penson DF. Racial variation in the quality of surgical care for prostate cancer. J Urol. 2012 Oct; 188(4):1279-85. PMID: 22902011.
      Citations: 14     Fields:    Translation:Humans
    112. Morgan TM, Kaffenberger SD, Cookson MS. Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol. 2012 Oct; 188(4):1081-8. PMID: 22901576.
      Citations: 7     Fields:    Translation:Humans
    113. Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan; 63(1):45-57. PMID: 22917985.
      Citations: 137     Fields:    Translation:Humans
    114. Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, Smith JA, Cookson MS. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology. 2012 Sep; 80(3):632-40. PMID: 22795379.
      Citations: 14     Fields:    Translation:Humans
    115. Anderson CB, Feurer ID, Large MC, Steinberg GD, Barocas DA, Cookson MS, Penson DF. Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index. Urology. 2012 Jul; 80(1):77-83. PMID: 22608798.
      Citations: 28     Fields:    Translation:Humans
    116. Anderson CB, Cookson MS, Chang SS, Clark PE, Smith JA, Kaufman MR. Voiding function in women with orthotopic neobladder urinary diversion. J Urol. 2012 Jul; 188(1):200-4. PMID: 22591966.
      Citations: 15     Fields:    Translation:Humans
    117. DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PLoS One. 2012; 7(5):e36669. PMID: 22590586.
      Citations: 41     Fields:    Translation:HumansAnimalsCTClinical Trials
    118. Cookson MS, Chang SS, Oefelein MG, Gallagher JR, Schwartz B, Heap K. National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer. J Urol. 2012 May; 187(5):1571-6. PMID: 22425105.
      Citations: 27     Fields:    Translation:Humans
    119. Anderson CB, Kaufman MR, Dietrich MS, Barocas DA, Chang SS, Cookson MS, Smith JA, Clark PE, Herrell SD. Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups. J Urol. 2012 Apr; 187(4):1346-51. PMID: 22341278.
      Citations: 6     Fields:    Translation:Humans
    120. Patel SG, Penson DF, Pabla B, Clark PE, Cookson MS, Chang SS, Herrell SD, Smith JA, Barocas DA. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol. 2012 Mar; 187(3):816-21. PMID: 22248514.
      Citations: 39     Fields:    Translation:Humans
    121. Anderson CB, Pyle AL, Woodworth A, Cookson MS, Smith JA, Barocas DA. Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):182-8. PMID: 22105412.
      Citations: 3     Fields:    Translation:Humans
    122. Davies JD, Aghazadeh MA, Phillips S, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Penson DF, Smith JA, Barocas DA. Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol. 2011 Dec; 186(6):2221-7. PMID: 22014803.
      Citations: 30     Fields:    Translation:Humans
    123. Kappa SF, Morgan TM, Keegan KA, Cookson MS. Inferior vena cava filter strut perforation discovered during right robotic-assisted laparoscopic partial nephrectomy. Urology. 2012 Apr; 79(4):e49-50. PMID: 22014963.
      Citations: 5     Fields:    Translation:Humans
    124. Broughton GJ, Clark PE, Barocas DA, Cookson MS, Smith JA, Herrell SD, Chang SS. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively. BJU Int. 2012 Jun; 109(11):1607-13. PMID: 21939493.
      Citations: 7     Fields:    Translation:Humans
    125. Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, Penson DF, Smith JA, Cookson MS. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol. 2013 Aug; 31(6):871-7. PMID: 21906965.
      Citations: 29     Fields:    Translation:Humans
    126. Shore N, Cookson MS, Gittelman MC. Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. BJU Int. 2012 Jan; 109(2):226-32. PMID: 21851539.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    127. Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA, Cookson MS. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011 Sep; 186(3):829-34. PMID: 21788035.
      Citations: 26     Fields:    Translation:Humans
    128. Keegan KA, Cookson MS. Complications of pelvic lymph node dissection for prostate cancer. Curr Urol Rep. 2011 Jun; 12(3):203-8. PMID: 21394597.
      Citations: 14     Fields:    Translation:Humans
    129. Anderson CB, Clark PE, Morgan TM, Stratton KL, Herrell SD, Davis R, Cookson MS, Smith JA, Chang SS. Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma. Urology. 2011 Jul; 78(1):99-104. PMID: 21550647.
      Citations: 8     Fields:    Translation:Humans
    130. Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts LJ, Morrow J, Concepcion RS, Smith JA, Fowke JH. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol. 2011 Jun; 185(6):2102-7. PMID: 21496850.
      Citations: 41     Fields:    Translation:Humans
    131. Whittam BM, Cookson MS, Rowland RG. Routine use of nasogastric tubes after radical cystectomy. J Urol. 2011 May; 185(5):1568-70. PMID: 21419435.
      Citations: 2     Fields:    Translation:Humans
    132. Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, Gregg JR, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011 Jun; 59(6):923-8. PMID: 21295907.
      Citations: 57     Fields:    Translation:Humans
    133. Fowke JH, Motley SS, Barocas DA, Cookson MS, Concepcion R, Byerly S, Smith JA. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer. Cancer Causes Control. 2011 Mar; 22(3):417-26. PMID: 21170754.
      Citations: 18     Fields:    Translation:Humans
    134. Thompson IM, Salem S, Chang SS, Clark PE, Davis R, Herrell SD, Kordan Y, Baumgartner R, Phillips S, Smith JA, Cookson MS, Barocas DA. Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods. World J Urol. 2011 Feb; 29(1):15-20. PMID: 21079968.
      Citations: 6     Fields:    Translation:Humans
    135. Aghazadeh MA, Barocas DA, Salem S, Clark PE, Cookson MS, Davis R, Gregg J, Stimson CJ, Smith JA, Chang SS. Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort. J Urol. 2011 Jan; 185(1):85-9. PMID: 21074199.
      Citations: 16     Fields:    Translation:Humans
    136. Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson CJ, Aghazadeh M, Smith JA, Barocas DA. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol. 2011 Jan; 185(1):90-6. PMID: 21074802.
      Citations: 84     Fields:    Translation:Humans
    137. Newton MR, Phillips S, Chang SS, Clark PE, Cookson MS, Davis R, Fowke JH, Herrell SD, Baumgartner R, Chan R, Mishra V, Blume JD, Smith JA, Barocas DA. Smaller prostate size predicts high grade prostate cancer at final pathology. J Urol. 2010 Sep; 184(3):930-7. PMID: 20643423.
      Citations: 15     Fields:    Translation:Humans
    138. Salem S, Chang SS, Clark PE, Davis R, Herrell SD, Kordan Y, Wills ML, Shappell SB, Baumgartner R, Phillips S, Smith JA, Cookson MS, Barocas DA. Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence. J Urol. 2010 Oct; 184(4):1334-40. PMID: 20723932.
      Citations: 3     Fields:    Translation:Humans
    139. Stimson CJ, Chang SS, Barocas DA, Humphrey JE, Patel SG, Clark PE, Smith JA, Cookson MS. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010 Oct; 184(4):1296-300. PMID: 20723939.
      Citations: 83     Fields:    Translation:Humans
    140. Stimson CJ, Cookson MS, Barocas DA, Clark PE, Humphrey JE, Patel SG, Smith JA, Chang SS. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol. 2010 May; 183(5):1732-7. PMID: 20299043.
      Citations: 24     Fields:    Translation:Humans
    141. Cookson MS, Chang SS. Margin control in open radical prostatectomy: what are the real outcomes? Urol Oncol. 2010 Mar-Apr; 28(2):205-9. PMID: 20219560.
      Citations: 3     Fields:    Translation:Humans
    142. Cookson MS. Should pelvic lymph node dissection be performed with radical prostatectomy? No. J Urol. 2010 Apr; 183(4):1284-5. PMID: 20171675.
      Citations: 2     Fields:    Translation:Humans
    143. Kordan Y, Barocas DA, Altamar HO, Clark PE, Chang SS, Davis R, Herrell SD, Baumgartner R, Mishra V, Chan RC, Smith JA, Cookson MS. Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Oct; 106(7):1036-40. PMID: 20151960.
      Citations: 25     Fields:    Translation:Humans
    144. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62. PMID: 20141680.
      Citations: 88     Fields:    Translation:Humans
    145. Barocas DA, Salem S, Kordan Y, Herrell SD, Chang SS, Clark PE, Davis R, Baumgartner R, Phillips S, Cookson MS, Smith JA. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival. J Urol. 2010 Mar; 183(3):990-6. PMID: 20083261.
      Citations: 34     Fields:    Translation:Humans
    146. Lerner SP, Bochner B, Linehan WM, Klein E, Cookson M. Overview of SUO Winter 2008 proceedings. Urol Oncol. 2010 Jan-Feb; 28(1):67-8. PMID: 20123350.
      Citations:    Fields:    Translation:Humans
    147. Kordan Y, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA, Barocas DA. Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol. 2009 Dec; 182(6):2695-701. PMID: 19836759.
      Citations: 11     Fields:    Translation:Humans
    148. Stec AA, Stratton KL, Kaufman MR, Chang SS, Milam DF, Herrell SD, Dmochowski RR, Smith JA, Clark PE, Cookson MS. Open renal biopsy: comorbidities and complications in a contemporary series. BJU Int. 2010 Jul; 106(1):102-6. PMID: 19874299.
      Citations: 2     Fields:    Translation:Humans
    149. Lowrance WT, Rumohr JA, Clark PE, Chang SS, Smith JA, Cookson MS. Urinary diversion trends at a high volume, single American tertiary care center. J Urol. 2009 Nov; 182(5):2369-74. PMID: 19758613.
      Citations: 14     Fields:    Translation:Humans
    150. Kordan Y, Chang SS, Salem S, Cookson MS, Clark PE, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA, Barocas DA. Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy. J Urol. 2009 Nov; 182(5):2291-5. PMID: 19758638.
      Citations: 13     Fields:    Translation:Humans
    151. Mitchell RE, Lee BT, Cookson MS, Barocas DA, Herrell SD, Clark PE, Smith JA, Chang SS. Immediate surgical outcomes for radical prostatectomy in the University HealthSystem Consortium Clinical Data Base: the impact of hospital case volume, hospital size and geographical region on 48,000 patients. BJU Int. 2009 Nov; 104(10):1442-5. PMID: 19681895.
      Citations: 7     Fields:    Translation:Humans
    152. Mitchell RE, Lee BT, Cookson MS, Barocas DA, Duke Herrell S, Clark PE, Smith JA, Chang SS. Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients. Cancer. 2009 Jun 01; 115(11):2447-52. PMID: 19309750.
      Citations: 3     Fields:    Translation:Humans
    153. Barocas DA, Mitchell R, Chang SS, Cookson MS. Impact of surgeon and hospital volume on outcomes of radical prostatectomy. Urol Oncol. 2010 May-Jun; 28(3):243-50. PMID: 19395287.
      Citations: 35     Fields:    Translation:Humans
    154. Barocas DA, Patel SG, Chang SS, Clark PE, Smith JA, Cookson MS. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology. BJU Int. 2009 Oct; 104(8):1091-7. PMID: 19389006.
      Citations: 3     Fields:    Translation:Humans
    155. Patel SG, Cookson MS, Barocas DA, Clark PE, Smith JA, Chang SS. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. BJU Int. 2009 Oct; 104(7):934-7. PMID: 19338554.
      Citations: 2     Fields:    Translation:Humans
    156. Fowke JH, Motley SS, Smith JA, Cookson MS, Concepcion R, Chang SS, Byerly S. Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume. J Urol. 2009 May; 181(5):2064-70. PMID: 19286210.
      Citations: 14     Fields:    Translation:Humans
    157. Milhoua PM, Miller NL, Cookson MS, Chang SS, Smith JA, Herrell SD. Primary endoscopic management versus open revision of ureteroenteric anastomotic strictures after urinary diversion--single institution contemporary series. J Endourol. 2009 Mar; 23(3):551-5. PMID: 19193136.
      Citations: 10     Fields:    Translation:Humans
    158. Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer. 2009 Feb 15; 115(4):770-5. PMID: 19152431.
      Citations: 4     Fields:    Translation:Humans
    159. Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. J Urol. 2009 Feb; 181(2):540-5; discussion 546. PMID: 19084855.
      Citations: 3     Fields:    Translation:Humans
    160. Coons BJ, Stec AA, Stratton KL, Chang SS, Cookson MS, Duke Herrell S, Smith JA, Clark PE. Prognostic factors in T3b renal cell carcinoma. World J Urol. 2009 Feb; 27(1):75-9. PMID: 19039590.
      Citations: 6     Fields:    Translation:Humans
    161. Clark PE, Cookson MS. The von Hippel-Lindau gene: turning discovery into therapy. Cancer. 2008 Oct 01; 113(7 Suppl):1768-78. PMID: 18800388.
      Citations: 11     Fields:    Translation:HumansCells
    162. Burgess EF, Ham AJ, Tabb DL, Billheimer D, Roth BJ, Chang SS, Cookson MS, Hinton TJ, Cheek KL, Hill S, Pietenpol JA. Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes. Proteomics Clin Appl. 2008 Jul 30; 2(9):1223. PMID: 20107526.
      Citations: 25     Fields:    
    163. Dahm P, Yeung LL, Chang SS, Cookson MS. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. J Urol. 2008 Aug; 180(2):451-9; discussion 460. PMID: 18550100.
      Citations: 15     Fields:    Translation:Humans
    164. Chan RC, Barocas DA, Chang SS, Herrell SD, Clark PE, Baumgartner R, Smith JA, Cookson MS. Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy. BJU Int. 2008 May; 101(9):1140-4. PMID: 18399829.
      Citations: 8     Fields:    Translation:Humans
    165. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2008 May; 179(5 Suppl):S27-32. PMID: 18405745.
      Citations: 5     Fields:    
    166. Stec AA, Coons BJ, Chang SS, Cookson MS, Herrell SD, Smith JA, Clark PE. Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival? J Urol. 2008 Jun; 179(6):2152-7. PMID: 18423724.
      Citations: 14     Fields:    Translation:Humans
    167. Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA, Cookson MS. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol. 2008 Apr; 179(4):1313-8; discussion 1318. PMID: 18289578.
      Citations: 39     Fields:    Translation:Humans
    168. Grossman HB, O'Donnell MA, Cookson MS, Greenberg RE, Keane TE. Bacillus calmette-guérin failures and beyond: contemporary management of non-muscle-invasive bladder cancer. Rev Urol. 2008; 10(4):281-9. PMID: 19145271.
      Citations: 9     
    169. Smith JA, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, Cookson MS. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol. 2007 Dec; 178(6):2385-9; discussion 2389-90. PMID: 17936849.
      Citations: 84     Fields:    Translation:Humans
    170. Patel SG, Cookson MS, Clark PE, Smith JA, Chang SS. Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management. BJU Int. 2008 Jan; 101(2):219-22. PMID: 17941923.
      Citations: 3     Fields:    Translation:Humans
    171. Fowke JH, Matthews CM, Buchowski MS, Signorello LB, Chang SS, Cookson MS, Blot WJ. Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate Cancer Prostatic Dis. 2008; 11(3):264-9. PMID: 17938644.
      Citations: 15     Fields:    Translation:Humans
    172. Barbieri CE, Lee B, Cookson MS, Bingham J, Clark PE, Smith JA, Chang SS. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol. 2007 Oct; 178(4 Pt 1):1418-21; discussion 1421-2. PMID: 17706712.
      Citations: 30     Fields:    Translation:Humans
    173. Schachter LR, Cookson MS, Chang SS, Smith JA, Dietrich MS, Jayaram G, Herrell SD. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol. 2007 Aug; 21(8):819-23. PMID: 17867935.
      Citations: 32     Fields:    Translation:Humans
    174. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007 Aug; 178(2):597-601. PMID: 17570435.
      Citations: 60     Fields:    Translation:Humans
    175. Chan RC, Hundemer GL, Tatsas A, Cookson MS. Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia. ScientificWorldJournal. 2007 Jun 12; 7:1000-3. PMID: 17619781.
      Citations: 1     Fields:    Translation:Humans
    176. Lowrance WT, Cookson MS, Clark PE, Smith JA, Chang SS. Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs. J Urol. 2007 Aug; 178(2):500-3; discussion 503. PMID: 17561148.
      Citations: 4     Fields:    Translation:Humans
    177. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007 Jun; 177(6):2106-31. PMID: 17509297.
      Citations: 370     Fields:    Translation:Humans
    178. Fleshner N, Gomella LG, Cookson MS, Finelli A, Evans A, Taneja SS, Lucia MS, Wolford E, Somerville MC, Rittmaster R. Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemp Clin Trials. 2007 Nov; 28(6):763-9. PMID: 17573244.
      Citations: 15     Fields:    Translation:Humans
    179. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, Droller MJ. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007 Jul; 178(1):68-73; discussion 73. PMID: 17499291.
      Citations: 84     Fields:    Translation:HumansCTClinical Trials
    180. Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, Petrylak DP, Benson MC, Partin AW, Garrett-Mayer E, Eisenberger MA. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol. 2007 May; 177(5):1777-81. PMID: 17437819.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    181. Fowke JH, Motley SS, Wills M, Cookson MS, Concepcion RS, Eckstein CW, Chang SS, Smith JA. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia. Cancer Causes Control. 2007 May; 18(4):375-84. PMID: 17334811.
      Citations: 7     Fields:    Translation:Humans
    182. Nelson B, Kaufman M, Broughton G, Cookson MS, Chang SS, Herrell SD, Baumgartner RG, Smith JA. Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol. 2007 Mar; 177(3):929-31. PMID: 17296378.
      Citations: 48     Fields:    Translation:Humans
    183. Kaufman MR, Baumgartner RG, Anderson LW, Smith JA, Chang SS, Herrell SD, Cookson MS. The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy. BJU Int. 2007 May; 99(5):1103-8. PMID: 17309550.
      Citations: 5     Fields:    Translation:Humans
    184. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007 Feb; 177(2):540-5. PMID: 17222629.
      Citations: 319     Fields:    Translation:Humans
    185. Palou J, Baniel J, Klotz L, Wood D, Cookson M, Lerner S, Horie S, Schoenberg M, Angulo J, Bassi P. Urothelial carcinoma of the prostate. Urology. 2007 Jan; 69(1 Suppl):50-61. PMID: 17280908.
      Citations: 8     Fields:    Translation:Humans
    186. Guise TA, Oefelein MG, Eastham JA, Cookson MS, Higano CS, Smith MR. Estrogenic side effects of androgen deprivation therapy. Rev Urol. 2007; 9(4):163-80. PMID: 18231613.
      Citations: 14     
    187. Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML, Smith JA. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis. 2007; 10(2):137-42. PMID: 17179979.
      Citations: 24     Fields:    Translation:Humans
    188. Jung C, Cookson MS, Chang SS, Smith JA, Dietrich MS, Teng M. Toxicity following high-dose salvage radiotherapy after radical prostatectomy. BJU Int. 2007 Mar; 99(3):529-33. PMID: 17155969.
      Citations: 4     Fields:    Translation:Humans
    189. Fowke JH, Signorello LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS, Ukoli FM, Blot WJ. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer. 2006 Nov 15; 107(10):2361-7. PMID: 17031814.
      Citations: 29     Fields:    Translation:Humans
    190. Girasole CR, Cookson MS, Smith JA, Ivey BS, Roth BJ, Chang SS. Sperm banking: use and outcomes in patients treated for testicular cancer. BJU Int. 2007 Jan; 99(1):33-6. PMID: 17034492.
      Citations: 18     Fields:    Translation:Humans
    191. Pitkänen-Arsiola T, Tillman JE, Gu G, Yuan J, Roberts RL, Wantroba M, Coetzee GA, Cookson MS, Kasper S. Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability. Prostate. 2006 Aug 01; 66(11):1177-93. PMID: 16652386.
      Citations: 15     Fields:    Translation:HumansCells
    192. Chang SS, Smith JA, Herrell SD, Cookson MS. Assessing urinary diversion experience in urologic residency programs-are we adequately training the next generation? J Urol. 2006 Aug; 176(2):691-3. PMID: 16813920.
      Citations: 5     Fields:    
    193. Chang SS, Cookson MS. Impact of positive surgical margins after radical prostatectomy. Urology. 2006 Aug; 68(2):249-52. PMID: 16904428.
      Citations: 13     Fields:    Translation:Humans
    194. Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Cookson MS. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2006 Jun; 97(6):1169-72. PMID: 16686706.
      Citations: 34     Fields:    Translation:Humans
    195. Hassan JM, Cookson MS, Smith JA, Chang SS. Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol. 2006 Jun; 175(6):2054-7. PMID: 16697802.
      Citations: 14     Fields:    Translation:Humans
    196. Kasper S, Cookson MS. Mechanisms leading to the development of hormone-resistant prostate cancer. Urol Clin North Am. 2006 May; 33(2):201-10, vii. PMID: 16631458.
      Citations: 18     Fields:    Translation:Humans
    197. Nelson BA, Chang SS, Cookson MS, Smith JA. Morbidity and efficacy of genitofemoral nerve grafts with radical retropubic prostatectomy. Urology. 2006 Apr; 67(4):789-92. PMID: 16584763.
      Citations: 4     Fields:    Translation:Humans
    198. Kaufman MR, Smith JA, Baumgartner RG, Wells N, Chang SS, Herrell SD, Cookson MS. Positive influence of robotically assisted laparoscopic prostatectomy on the collaborative-care pathway for open radical prostatectomy. BJU Int. 2006 Mar; 97(3):473-5. PMID: 16469010.
      Citations: 3     Fields:    Translation:Humans
    199. Girasole CR, Cookson MS, Putzi MJ, Chang SS, Smith JA, Wells N, Oppenheimer JR, Shappell SB. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy. J Urol. 2006 Mar; 175(3 Pt 1):929-33; discussion 933. PMID: 16469583.
      Citations: 5     Fields:    Translation:Humans
    200. Chang SS, Cookson MS. Non-muscle-invasive bladder cancer: the role of radical cystectomy. Urology. 2005 Nov; 66(5):917-22. PMID: 16286095.
      Citations: 7     Fields:    Translation:Humans
    201. Webster TM, Herrell SD, Chang SS, Cookson MS, Baumgartner RG, Anderson LW, Smith JA. Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a prospective assessment of postoperative pain. J Urol. 2005 Sep; 174(3):912-4; discussion 914. PMID: 16093986.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    202. Chang SS, Cole E, Smith JA, Baumgartner R, Wells N, Cookson MS. Safely reducing length of stay after open radical retropubic prostatectomy under the guidance of a clinical care pathway. Cancer. 2005 Aug 15; 104(4):747-51. PMID: 15999365.
      Citations: 10     Fields:    Translation:Humans
    203. Chang SS, Ivey B, Smith JA, Roth BJ, Cookson MS. Performance-enhancing supplement use in patients with testicular cancer. Urology. 2005 Aug; 66(2):242-5. PMID: 16098349.
      Citations: 2     Fields:    Translation:Humans
    204. Parekh DJ, Cookson MS, Chapman W, Harrell F, Wells N, Chang SS, Smith JA. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol. 2005 Jun; 173(6):1897-902. PMID: 15879771.
      Citations: 33     Fields:    Translation:HumansCells
    205. Chang SS, Cookson MS. Radical cystectomy for bladder cancer: the case for early intervention. Urol Clin North Am. 2005 May; 32(2):147-55. PMID: 15862612.
      Citations: 8     Fields:    Translation:Humans
    206. Cookson MS. The surgical management of muscle invasive bladder cancer: a contemporary review. Semin Radiat Oncol. 2005 Jan; 15(1):10-8. PMID: 15662602.
      Citations: 10     Fields:    Translation:Humans
    207. Hassan JM, Cookson MS, Smith JA, Chang SS. Urethral recurrence in patients following orthotopic urinary diversion. J Urol. 2004 Oct; 172(4 Pt 1):1338-41. PMID: 15371836.
      Citations: 16     Fields:    Translation:Humans
    208. Chang SS, Alberts GL, Smith JA, Cookson MS. Ileal conduit urinary diversion in patients with previous history of abdominal/pelvic irradiation. World J Urol. 2004 Oct; 22(4):272-6. PMID: 15448995.
      Citations: 7     Fields:    Translation:Humans
    209. Hassan JM, Cookson MS, Smith JA, Johnson DL, Chang SS. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol. 2004 Sep; 172(3):882-4. PMID: 15310989.
      Citations: 4     Fields:    Translation:Humans
    210. Farnham SB, Cookson MS. Surgical complications of urinary diversion. World J Urol. 2004 Sep; 22(3):157-67. PMID: 15316737.
      Citations: 35     Fields:    Translation:Humans
    211. Nelson BA, Cookson MS, Smith JA, Chang SS. Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol. 2004 Aug; 172(2):494-7. PMID: 15247712.
      Citations: 12     Fields:    Translation:Humans
    212. Shuford MD, Cookson MS, Chang SS, Shintani AK, Tsiatis A, Smith JA, Shappell SB. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy. J Urol. 2004 Jul; 172(1):119-23. PMID: 15201750.
      Citations: 8     Fields:    Translation:Humans
    213. Farnham SB, Cookson MS, Alberts G, Smith JA, Chang SS. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol. 2004 May-Jun; 22(3):178-81. PMID: 15271311.
      Citations: 16     Fields:    Translation:Humans
    214. Chang SS, Duong DT, Wells N, Cole EE, Smith JA, Cookson MS. Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index. J Urol. 2004 May; 171(5):1861-5. PMID: 15076294.
      Citations: 19     Fields:    Translation:Humans
    215. Shuford MD, McDougall EM, Chang SS, LaFleur BJ, Smith JA, Cookson MS. Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approach. Urol Oncol. 2004 Mar-Apr; 22(2):121-6. PMID: 15082009.
      Citations: 18     Fields:    Translation:Humans
    216. Chang SS, Jacobs B, Wells N, Smith JA, Cookson MS. Increased body mass index predicts increased blood loss during radical cystectomy. J Urol. 2004 Mar; 171(3):1077-9. PMID: 14767274.
      Citations: 12     Fields:    Translation:Humans
    217. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004 Feb; 171(2 Pt 1):646-51. PMID: 14713778.
      Citations: 34     Fields:    Translation:Humans
    218. Cole EE, DeSouza R, Shappell S, Cookson MS. Primary renal carcinoid tumor. J Urol. 2004 Jan; 171(1):338. PMID: 14665914.
      Citations: 2     Fields:    Translation:Humans
    219. Cookson MS, Dutta SC, Chang SS, Clark T, Smith JA, Wells N. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol. 2003 Nov; 170(5):1926-30. PMID: 14532809.
      Citations: 38     Fields:    Translation:Humans
    220. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003 Oct; 170(4 Pt 1):1085-7. PMID: 14501697.
      Citations: 38     Fields:    Translation:Humans
    221. Baldwin DD, Dunbar JA, Parekh DJ, Wells N, Shuford MD, Cookson MS, Smith JA, Herrell SD, Chang SS, McDougall EM. Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk. J Endourol. 2003 Apr; 17(3):161-7. PMID: 12803988.
      Citations: 5     Fields:    Translation:Humans
    222. Chang SS, Smith JA, Cookson MS. Decreasing blood loss in patients treated with radical cystectomy: a prospective randomizes trial using a new stapling device. J Urol. 2003 Mar; 169(3):951-4. PMID: 12576820.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    223. Adkins KL, Chang SS, Cookson MS, Smith JA. Partial nephrectomy safely preserves renal function in patients with a solitary kidney. J Urol. 2003 Jan; 169(1):79-81. PMID: 12478108.
      Citations: 8     Fields:    Translation:Humans
    224. Cookson MS, Chang SS, Wells N, Parekh DJ, Smith JA. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. J Urol. 2003 Jan; 169(1):101-4. PMID: 12478113.
      Citations: 29     Fields:    Translation:Humans
    225. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER, Wells N, Smith J. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol. 2003 Jan; 169(1):145-7; discussion 147-8. PMID: 12478123.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    226. Parekh DJ, Clark T, O'Connor J, Jung C, Chang SS, Cookson M, Smith JA. Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions. J Urol. 2002 Dec; 168(6):2454-6. PMID: 12441938.
      Citations: 6     Fields:    Translation:Humans
    227. Chang SS, Cole E, Cookson MS, Peterson M, Smith JA. Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results. J Urol. 2002 Oct; 168(4 Pt 1):1442-5. PMID: 12352414.
      Citations: 24     Fields:    Translation:Humans
    228. Baumgartner RG, Wells N, Chang SS, Cookson MS, Smith JA. Causes of increased length of stay following radical cystectomy. Urol Nurs. 2002 Oct; 22(5):319-23, 339. PMID: 12432717.
      Citations: 4     Fields:    Translation:Humans
    229. Grossklaus DJ, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS. The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urol Oncol. 2002 Sep-Oct; 7(5):195-8. PMID: 12644216.
      Citations: 6     Fields:    Translation:Humans
    230. Chang SS, Smith JA, Girasole C, Baumgartner RG, Roth BJ, Cookson MS. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection. J Urol. 2002 Jul; 168(1):87-92. PMID: 12050498.
      Citations: 1     Fields:    Translation:Humans
    231. Chang SS, Cole E, Smith JA, Cookson MS. Pathological findings of gynecologic organs obtained at female radical cystectomy. J Urol. 2002 Jul; 168(1):147-9. PMID: 12050510.
      Citations: 13     Fields:    Translation:Humans
    232. Dutta SC, Chang SC, Coffey CS, Smith JA, Jack G, Cookson MS. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002 Jul; 168(1):164-7. PMID: 12050514.
      Citations: 49     Fields:    Translation:Humans
    233. Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol. 2002 May; 167(5):2012-6. PMID: 11956429.
      Citations: 72     Fields:    Translation:Humans
    234. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Chang SS, Cookson MS. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol. 2002 May; 167(5):2032-5; discussion 2036. PMID: 11956432.
      Citations: 15     Fields:    Translation:Humans
    235. Clark T, Chang SS, Cookson MS. Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy. J Urol. 2002 Apr; 167(4):1795. PMID: 11912421.
      Citations: 3     Fields:    Translation:Humans
    236. Chang SS, Cookson MS, Hassan JM, Wells N, Smith JA. Routine postoperative intensive care monitoring is not necessary after radical cystectomy. J Urol. 2002 Mar; 167(3):1321-4. PMID: 11832723.
      Citations: 4     Fields:    Translation:Humans
    237. Nixon RG, Chang SS, Lafleur BJ, Smith JA JA, Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol. 2002 Feb; 167(2 Pt 1):502-5. PMID: 11792906.
      Citations: 15     Fields:    Translation:Humans
    238. Chang SS, Nayak R, Cookson MS. Lymphoma presenting as a solitary renal hilar mass. Urology. 2002 Jan; 59(1):134-5. PMID: 11796299.
      Citations: 1     Fields:    Translation:Humans
    239. Chang SS, Baumgartner RG, Wells N, Cookson MS, Smith JA. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol. 2002 Jan; 167(1):208-11. PMID: 11743307.
      Citations: 34     Fields:    Translation:Humans
    240. Chang SS, Smith JA, Wells N, Peterson M, Kovach B, Cookson MS. Estimated blood loss and transfusion requirements of radical cystectomy. J Urol. 2001 Dec; 166(6):2151-4. PMID: 11696725.
      Citations: 19     Fields:    Translation:Humans
    241. Chang SS, Alberts G, Wells N, Smith JA, Cookson MS. Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial. J Urol. 2001 Dec; 166(6):2178-80. PMID: 11696730.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    242. Pietrow PK, Parekh DJ, Smith JA, Shyr Y, Cookson MS. Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. J Urol. 2001 Dec; 166(6):2286-90. PMID: 11696753.
      Citations: 6     Fields:    Translation:Humans
    243. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Cookson MS. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int. 2001 Nov; 88(7):722-6. PMID: 11890243.
      Citations: 6     Fields:    Translation:Humans
    244. Chang SS, Alberts G, Cookson MS, Smith JA. Radical cystectomy is safe in elderly patients at high risk. J Urol. 2001 Sep; 166(3):938-41. PMID: 11490250.
      Citations: 22     Fields:    Translation:Humans
    245. Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 2001 Aug; 166(2):490-3. PMID: 11458053.
      Citations: 50     Fields:    Translation:Humans
    246. Grossklaus DJ, Shappell SB, Gautam S, Smith JA, Cookson MS. Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen. J Urol. 2001 Feb; 165(2):455-8. PMID: 11176395.
      Citations: 3     Fields:    Translation:Humans
    247. Cookson MS. Update on transrectal ultrasound-guided needle biopsy of the prostate. Mol Urol. 2000; 4(3):93-7; discussion 99. PMID: 11062362.
      Citations: 3     Fields:    Translation:Humans
    248. Amos AM, Figlesthaler WM, Cookson MS. Bilateral ureteritis cystica with unilateral ureteropelvic junction obstruction. Tech Urol. 1999 Jun; 5(2):108-12. PMID: 10458667.
      Citations: 2     Fields:    Translation:Humans
    249. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. [Incidence and clinical significance of false-negative sextant biopsies of the prostate]. Urologe A. 1998 Nov; 37(6):660. PMID: 9887497.
      Citations: 1     Fields:    Translation:Humans
    250. Fleshner NE, Cookson MS, Soloway SM, Fair WR. Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer. Urology. 1998 Oct; 52(4):659-62. PMID: 9763089.
      Citations: 9     Fields:    Translation:Humans
    251. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998 Apr; 159(4):1247-50. PMID: 9507846.
      Citations: 70     Fields:    Translation:HumansCTClinical Trials
    252. Stroumbakis N, Herr HW, Cookson MS, Fair WR. Radical cystectomy in the octogenarian. J Urol. 1997 Dec; 158(6):2113-7. PMID: 9366325.
      Citations: 25     Fields:    Translation:Humans
    253. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol. 1997 Jul; 158(1):62-7. PMID: 9186324.
      Citations: 112     Fields:    Translation:HumansCTClinical Trials
    254. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy. Urology. 1997 Jun; 49(6):887-93. PMID: 9187696.
      Citations:    Fields:    Translation:Humans
    255. Cookson MS, Sogani PC, Russo P, Sheinfeld J, Herr H, Dalbagni G, Reuter VE, Begg CB, Fair WR. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. Br J Urol. 1997 Mar; 79(3):432-8. PMID: 9117227.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    256. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology. 1997 Mar; 49(3A Suppl):113-8. PMID: 9123730.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    257. Fair WR, Cookson MS, Stroumbakis N, Cohen D, Aprikian AG, Wang Y, Russo P, Soloway SM, Sogani P, Sheinfeld J, Herr H, Dalgabni G, Begg CB, Heston WD, Reuter VE. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology. 1997 Mar; 49(3A Suppl):46-55. PMID: 9123736.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    258. Su SL, Heston WD, Perrotti M, Cookson MS, Stroumbakis N, Huyrk R, Edwards E, Brander B, Coke J, Soloway S, Lewis A, Fair WR, Perroti M. Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. Urology. 1997 Mar; 49(3A Suppl):95-101. PMID: 9123743.
      Citations: 4     Fields:    Translation:HumansCells
    259. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol. 1997 Feb; 157(2):559-62. PMID: 8996356.
      Citations: 46     Fields:    Translation:Humans
    260. Cookson MS, Reuter VE, Linkov I, Fair WR. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol. 1997 Feb; 157(2):673-6. PMID: 8996396.
      Citations: 22     Fields:    Translation:Humans
    261. Herr HW, Cookson MS, Soloway SM. Upper tract tumors in patients with primary bladder cancer followed for 15 years. J Urol. 1996 Oct; 156(4):1286-7. PMID: 8808855.
      Citations: 11     Fields:    Translation:Humans
    262. Cookson MS, Floyd MK, Ball TP, Miller EK, Sarosdy MF. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol. 1995 Sep; 154(3):1070-3. PMID: 7543601.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    263. Cookson MS, Witt MA, Kimball KT, Grantmyre JE, Lipshultz LI. Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility? World J Urol. 1995; 13(5):318-22. PMID: 8581004.
      Citations: 1     Fields:    Translation:Humans
    264. Houser EE, Bartholomew TH, Cookson MS, Marlin AE, Little NA. A prospective evaluation of leak point pressure, bladder compliance and clinical status in myelodysplasia patients with tethered spinal cords. J Urol. 1994 Jan; 151(1):177-80; discussion 180-1. PMID: 8254809.
      Citations: 6     Fields:    Translation:Humans
    265. Cookson MS, Sarosdy MF. Hormonal therapy for metastatic prostate cancer: issues of timing and total androgen ablation. South Med J. 1994 Jan; 87(1):1-6. PMID: 8284708.
      Citations: 4     Fields:    Translation:Humans
    266. Cookson MS, Phillips DL, Huff ME, Fitch WP. Analysis of microsurgical penile revascularization results by etiology of impotence. J Urol. 1993 May; 149(5 Pt 2):1308-12. PMID: 8479022.
      Citations: 2     Fields:    Translation:Humans
    267. Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol. 1993 Feb; 149(2):290-4. PMID: 8426404.
      Citations: 21     Fields:    Translation:Humans
    268. Cookson MS, Sarosdy MF. Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol. 1992 Sep; 148(3):797-801. PMID: 1512829.
      Citations: 12     Fields:    Translation:Humans
    Cookson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (569)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _